1.
Rubini N, Ensina L, Silva E, Sano F, Solé D. Effectiveness and safety of Omalizumab in the treatment of chronic spontaneous urticaria: Systematic review and meta-analysis. Allergol Immunopathol. 2019;47(6):515-522. Accessed September 10, 2025. https://all-imm.com/index.php/aei/article/view/264